Emily Pimblett insider trades: Climb Bio (CLYM) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Emily reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 20, 2025 | CLYM | ↓ Sell | 1,242 | $1.24 | $2K | Direct | Jun 20, 2025 (0d) |
| Mar 20, 2025 | CLYM | ↓ Sell | 1,199 | $1.31 | $2K | Direct | Mar 20, 2025 (0d) |
| Dec 19, 2024 | CLYM | ↓ Sell | 1,235 | $2.02 | $2K | Direct | Dec 20, 2024 (1d) |
| Sep 20, 2024 | ELYM | ↓ Sell | 1,191 | $8.18 | $10K | Direct | Sep 20, 2024 (0d) |
| Jun 20, 2024 | ELYM | ↓ Sell | 1,245 | $7.21 | $9K | Direct | Jun 21, 2024 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other CLYM insiders
Open-market trades in the last 12 months
About Emily Pimblett's insider trades
Emily Pimblett is SVP, Finance & CAO at Climb Bio (CLYM). Since Jun 20, 2024, Emily has reported no open-market purchases and 5 sales worth $24K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include option exercises (6 filings), grants and awards (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CLYM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.